Piao, Wenji https://orcid.org/0000-0003-0005-3930
Wu, Long
Xiong, Yanbao
Zapas, Gregory C.
Paluskievicz, Christina M.
Oakes, Robert S. https://orcid.org/0000-0003-3783-6488
Pettit, Sarah M.
Sleeth, Margaret L. https://orcid.org/0009-0007-2147-9670
Hippen, Keli L. https://orcid.org/0000-0002-8050-270X
Schmitz, Jessica
Ivanyi, Philipp https://orcid.org/0000-0002-2862-7302
Shetty, Amol C. https://orcid.org/0000-0001-8790-7649
Song, Yang
Kong, Dejun
Lee, Young
Li, Lushen
Shirkey, Marina W.
Kensiski, Allison https://orcid.org/0000-0003-4813-8917
Alvi, Aamna
Ho, Kevin
Saxena, Vikas https://orcid.org/0000-0003-4816-4875
Bräsen, Jan H.
Jewell, Christopher M. https://orcid.org/0000-0002-6668-6928
Blazar, Bruce R. https://orcid.org/0000-0002-9608-9841
Abdi, Reza
Bromberg, Jonathan S. https://orcid.org/0000-0002-1407-8795
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (R37 AI062765)
Emerald grant 2022 to JSB and WP.
Article History
Received: 5 March 2024
Accepted: 25 November 2024
First Online: 2 December 2024
Competing interests
: J.S.B., W.P., and X.Y. are inventors on a patent related to LTβR antagonists entitled “Inhibitors of LTβR-NFκB signaling pathways for treating inflammation and cancer” (Patent number: 11590202). The remaining authors declare no competing interests.